Ixazomib Citrate (MLN9708)
CAS:
Ref. 3D-BYB90280
5mg
315.00€
10mg
342.00€
25mg
570.00€
50mg
863.00€
100mg
1,302.00€
Product Information
Name:Ixazomib Citrate (MLN9708)
Brand:Biosynth
Description:Ixazomib Citrate (MLN9708) is a proteasome inhibitor that belongs to the class of investigational agents. It has minimal toxicity and is being investigated for use in the treatment of multiple myeloma, a type of cancer that starts in the bone marrow. Ixazomib Citrate inhibits the activity of proteasomes, which are cellular structures responsible for degrading proteins. This inhibition leads to an increase in the number of cells with damaged DNA and an increase in apoptosis. Ixazomib Citrate synergizes with other chemotherapeutic agents, such as bortezomib, to promote apoptosis by activating caspases and decreasing cell proliferation. The biochemical properties of this drug include its ability to inhibit protein synthesis by inhibiting eukaryotic ribosomes and its ability to bind to DNA at specific sites.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:517.12 g/mol
Formula:C20H23BCl2N2O9
Purity:Min. 95%
Technical inquiry about: Ixazomib Citrate (MLN9708)
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.